Ashion Analytics is a Biotechnology and Health Care startup founded in 2014. The company, now part of Genomic Health, Inc., is a CAP-accredited and CLIA-certified clinical genomics testing laboratory specializing in personalized options for cancer treatment. Their flagship offering, the GEM ExTra®, provides a comprehensive genomic assessment for clinical cancer testing, covering all DNA-coding regions and including full RNA analysis of the human genome. Ashion Analytics aims to accelerate the adoption of precision medicine in mainstream oncology by leveraging their scientific and clinical experience. Their services cater to Physicians, Health Systems, Research, and Commercial partners, empowering them to provide precision cancer treatments. With a focus on sequencing-based clinical laboratory services, their slogan "We tap into the power of the human genome" underscores their commitment to advancing healthcare through genomic insights.
There is no investment information
No recent news or press coverage available for Ashion Analytics.